AADC polynucleotides for the treatment of Parkinson's disease
US11027000B2 · kind B2 · utility
2Cited by
250References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2019 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Aug 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.